Email this page Print this page

Article Addendum

Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2’-O-Me-cAMP-AM

Grant G. Kelley, Oleg G. Chepurny, Frank Schwede, Hans-G. Genieser, Colin A. Leech, Michael W. Roe, Xiangquan Li, Igor Dzhura, Elvira Dzhura, Parisa Afshari and George G. Holz
Volume 1, Issue 3
November/December 2009
Pages 260 - 265
DOI: 10.4161/isl.1.3.9645

This is an open-access article


 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.



Epac2 is a cAMP-regulated guanine nucleotide exchange factor (cAMP-GEF) that is proposed to mediate stimulatory actions of the second messenger cAMP on mouse islet insulin secretion. Here we have used methods of islet perifusion to demonstrate that the acetoxymethyl ester (AM-ester) of an Epac-selective cAMP analog (ESCA) penetrates into mouse islets and is capable of potentiating both first and second phases of glucose-stimulated insulin secretion (GSIS). When used at low concentrations (1-10 μM), 8-pCPT-2’-O-Me-cAMP-AM activates Rap1 GTPase but exhibits little or no ability to activate protein kinase A (PKA), as validated in assays of in vitro PKA activity (phosphorylation of Kemptide), Ser133 CREB phosphorylation status, RIP1-CRE-Luc reporter gene activity, and PKA-dependent AKAR3 biosensor activation. Since quantitative PCR demonstrates Epac2 mRNA to be expressed at levels ca. 5.3-fold greater than that of Epac1, available evidence indicates that Epac2 does in fact mediate stimulatory actions of cAMP on mouse islet GSIS.

Chepurny OG, Leech CA, Kelley GG, Dzhura I, Dzhura E, Li X, et al. Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: studies with 8-pCPT-2’-O-Me-cAMP-AM. J Biol Chem. 2009; 284:10728-36. PMID: 19244230; DOI: 10.1074/jbc.M900166200


Authors

Grant G. Kelley
Department of Medicine, State University of New York Upstate Medical University Syracuse, NY, USA
Oleg G. Chepurny
Department of Medicine, State University of New York Upstate Medical University Syracuse, NY, US
Frank Schwede
BIOLOG Life Science Institute, Bremen, Germany
Hans-G. Genieser
BIOLOG Life Science Institute, Bremen, Germany
Colin A. Leech
Department of Medicine, State University of New York Upstate Medical University Syracuse, NY, USA
Michael W. Roe
Department of Medicine, State University of New York Upstate Medical University Syracuse, NY, USA
Xiangquan Li
Department of Medicine, State University of New York Upstate Medical University Syracuse, NY, USA
Igor Dzhura
Department of Medicine, State University of New York Upstate Medical University Syracuse, NY, USA
Elvira Dzhura
Department of Medicine, State University of New York Upstate Medical University Syracuse, NY, USA
Parisa Afshari
Department of Medicine, State University of New York Upstate Medical University Syracuse, NY, USA
George G. Holz Corresponding author: holzg@upstate.edu
Department of Medicine, State University of New York Upstate Medical University Syracuse, NY, USA

This is an open-access article


 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

Advertisements